Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab plus platinum/etoposide vs placebo plus platinum/etoposide in extensive-stage small cell lung cancer
CTR20130574Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ipilimumab in small cell lung cancer (SCLC), sponsored by Bristol Myers Squibb. Started Mar 2014; status: completed.
02
Drugs
ipilimumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on CTR20130574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130574.